http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0629188-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-01
filingDate 1987-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1994-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0629188-B2
titleOfInvention Anti-cancer agent and revertant cell acquisition agent
priorityDate 1987-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID141614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID477547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415821915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122047
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424899853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1903
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID141614

Total number of triples: 31.